Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista colombiana de Gastroenterología
versión impresa ISSN 0120-9957
Resumen
MOSQUERA-KLINGER, Gabriel Alonso; ZAMBRANO-GUSTIN, María Alejandra y CARVAJAL, Jhon Jaime. Case Report of Vedolizumab Treatment of Refractory Ulcerative Colitis Associated with Psoriasis. Rev Col Gastroenterol [online]. 2019, vol.34, n.1, pp.79-84. ISSN 0120-9957. https://doi.org/10.22516/25007440.203.
The patient had a long history of difficult to control psoriasis and ulcerative colitis and was dependent on corticosteroids. Multiple treatment schemes including several attempts with tumor necrosis factor (anti-TNF) antagonists had had acceptable clinical responses but subsequently lost effectiveness. During acute exacerbation of colitis, vedolizumab was used and achieved remarkable clinical improvement. During maintenance, deep healing was achieved (endoscopic and histological normalization). In addition, there was significant improvement of psoriasis lesions during follow-up.
This is the first case to be published of the use of Vedolizumab to treat this condition in Colombia.
Palabras clave : Biological therapy; psoriasis; ulcerative colitis; vedolizumab.